| Financial Year |
March 31 2023 |
| Monetary Funds |
170,917,377.22 |
| Held-for-trading Financial Assets |
8,177,166.67 |
| Notes Receivable |
-- |
| Accounts Receivable |
369,685,164.43 |
| Advances to Suppliers |
-- |
| Other Receivables |
16,401,683.03 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
212,582,425.50 |
| Other Current Assets |
80,107,489.89 |
| Total Current Assets |
1,349,485,670.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
46,173,774.18 |
| Long-term Equity Investment |
65,067,502.79 |
| Investment Properties |
7,623,702.46 |
| Fixed Assetes |
9,573,855.48 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
14,069,030.43 |
| R&D expenses |
-- |
| Goodwill |
21,542,998.13 |
| Long-Term Deferred and Prepaid Expenses |
2,195,016.39 |
| Deferred Income Tax Assets |
30,102,241.51 |
| Other Non-Current Assets |
1,305,548,685.05 |
| Sub-Total of Non-Current Assets |
1,539,543,669.21 |
| Total Assets |
2,889,029,340.05 |
| Short-Term Loans |
253,473,744.44 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
548,939,465.14 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,393,704.20 |
| Taxes Payable |
70,351,093.80 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,869,133.21 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
84,499,111.77 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
968,157,299.46 |
| Long-term Loans |
1,001,863,894.48 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
31,930,349.22 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,041,798,462.95 |
| Total Liabilities |
2,009,955,762.41 |
| Paid-In Capital(Or Share Stock) |
264,264,000.00 |
| Capital Surplus |
277,175,587.62 |
| Surplus Reserve |
43,657,645.42 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
268,334,949.91 |
| Minority Stockholder's Interest |
25,641,394.69 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
853,432,182.95 |
| Owner's Equity（Stockholder's Equity） |
879,073,577.64 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,889,029,340.05 |
